Showing results (111-120 of 4,318) with videos related to
Sort By:
Pageof 432
Cancer Immunology, Immunotherapy : CII|August 15, 2000
Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attackE S Bergmann-Leitner, S I AbramsMicrobes and Infection|April 7, 2004
Danger, death and DNA vaccinesElke S Bergmann-Leitner, Wolfgang W LeitnerJournal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTLE S Bergmann-Leitner, S I AbramsArchives of Disease in Childhood|May 14, 1998
Oestrogen treatment of constitutional tall stature: a risk-benefit ratioE Weimann, S Bergmann, H J BöhlesResearch in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1994
Regeneration of splenic stromal elementsW Leitner, E S Bergmann, J ThalhamerRheumatology (Oxford, England)|September 29, 2005
Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysisE Ben-Chetrit, S Bergmann, R SoodVaccines|September 8, 2015
Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsElke S Bergmann-Leitner, Wolfgang W LeitnerClinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 1996
Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjectsW Leonhardt, M Hanefeld, G Müller, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2002
Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytesE S Bergmann-Leitner, S I AbramsCellular Immunology|June 21, 2001
Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactionsE S Bergmann-Leitner, S I AbramsPageof 432